Primaire tabs

Zoeken
Limit to
Exporteer 223 resultaten:
Filters: Auteur is M. Arbyn
2023
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework., Dhillon, Sharon, Cocuzza Clementina E., Chung Pui Yan Jen, Martinelli Marianna, Giubbi Chiara, Njoku Ruth C., Bhatia Ramya, Cuschieri Kate, and Arbyn M. , J Med Virol, 2023 Jan, Volume 95, Issue 1, (2023)
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis., Bruni, Laia, Albero Ginesa, Rowley Jane, Alemany Laia, Arbyn M., Giuliano Anna R., Markowitz Lauri E., Broutet Nathalie, and Taylor Melanie , Lancet Glob Health, 2023 Sep, Volume 11, Issue 9, (2023)
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative., Singh, Deependra, Vignat Jerome, Lorenzoni Valentina, Eslahi Marzieh, Ginsburg Ophira, Lauby-Secretan Beatrice, Arbyn M., Basu Partha, Bray Freddie, and Vaccarella Salvatore , Lancet Glob Health, 2023 Feb, Volume 11, Issue 2, (2023)
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial., Glinska, Patrycja, Komerska Katarzyna, Janik Beata, Olkowicz Julia, Jedrzejewska Ilona, Macios Anna, Wieszczy Paulina, Kaminski Michal F., Arbyn M., and Nowakowski Andrzej , BMC Cancer, 2023 Nov 17, Volume 23, Issue 1, (2023)
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions., Arbyn, M., Costa Stefanie, Latsuzbaia Ardashel, Kellen Eliane, Girogi Rossi Paolo, Cocuzza Clementina E., Basu Partha, and Castle Philip E. , Cancer Epidemiol Biomarkers Prev, 2023 Feb 06, Volume 32, Issue 2, (2023)
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020)., Mwenda, Valerian, Bor Joan-Paula, Nyangasi Mary, Njeru James, Olwande Sharon, Njiri Patricia, Arbyn M., Weyers Steven, Tummers Philippe, and Temmerman Marleen , PLoS One, 2023, Volume 18, Issue 5, (2023)
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay., Dhillon, Sharon, Chung Pui Yan Jen, Padalko Elizaveta, Praet Marleen, Pereira Ana Rita, Redzic Nina, Broeck Davy Vanden, and Arbyn M. , J Med Virol, 2023 Sep, Volume 95, Issue 9, (2023)
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues., Garland, Suzanne M., Iftner Thomas, Cuschieri Kate, Kaufmann Andreas M., Arbyn M., de Sanjosé Silvia, Poljak Mario, Dillner Joakim, and Unger Elizabeth R. , J Clin Virol, 2023 Feb, Volume 159, (2023)
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework., Bhatia, Ramya, Alcaniz Boada Elia, Hansen Bonde, Jesper, Quint Wim G. V., Lan Xu, Moller Ejegod, Ditte, Cuschieri Kate, and Arbyn M. , J Clin Pathol, March 2023 , Volume 76, Issue 3, (2023)
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management., Bowden, Sarah J., Burney Ellis, Laura, Kalliala Ilkka, Paraskevaidi Maria, Tighe Jack, Kechagias Konstantinos S., Doulgeraki Triada, Paraskevaidis Evangelos, Arbyn M., Flanagan James, et al. , BMJ Open, 2023 Jun 05, Volume 13, Issue 6, (2023)
2022
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer, Simoens, Cindy, Gheit Tarik, Ridder Ruediger, Gorbaslieva Ivana, Holzinger Dana, Lucas Eric, Rehm Susanne, Vermeulen Peter, Lammens Martin, Vanderveken Olivier, et al. , BMC Infectious Diseases , 06 August 2022, Volume 22, (2022)
HPV and head and neck cancers: Towards early diagnosis and prevention., Galati, Luisa, Chiocca Susanna, Duca Daria, Tagliabue Marta, Simoens Cindy, Gheit Tarik, Arbyn M., and Tommasino Massimo , Tumour Virus Res, 2022 Aug 13, Volume 14, (2022)
The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study, Gorasso, Vanessa, Silversmit Geert, Arbyn M., Cornez Astrid, De Pauw Robby, De Smedt Delphine, Grant Ian, Wyper Grant M. A., Devleesschauwer Brecht, and Speybroeck Niko , BMC Cancer, Jan-12-2022, Volume 22, Issue 1, (2022)
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening, Costa, Stefanie, Verberckmoes Bo, Castle Philip E., and Arbyn M. , British Journal of Cancer, 14/12/2022, (2022)
Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening., Lefeuvre, Caroline, De Pauw H, Le Duc Banaszuk Anne-Sophie, Pivert Adeline, Ducancelle Alexandra, Rexand-Galais Franck, and Arbyn M. , Int J Public Health, 2022, Volume 67, (2022)
VALCOR: a protocol for the validation of SARS-corona virus-2 assays., Arbyn, M., Dhillon Sharon, Martinelli Marianna, Simoens Cindy, Cuypers Lize, Bode Jannes, Van Ranst Marc, Corbisier Philippe, Bonde Jesper, and Cocuzza Clementina , Arch Public Health, 2022 Mar 29, Volume 80, Issue 1, (2022)
VALCOR: a protocol for the validation of SARS-corona virus-2 assays, Arbyn, M., Dhillon Sharon, Martinelli Marianna, Simoens Cindy, Cuypers Lize, Bode Jannes, Van Ranst Marc, Corbisier Philippe, Bonde Jesper, and Cocuzza Clementina , Archives of Public Health, Jan-12-2022, Volume 80, Issue 1, (2022)
2021
Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study, De Pauw, H, Donders Gilbert, Weyers Steven, De Sutter Philippe, Doyen Jean, Tjalma Wiebren A. A., Broeck Davy Vanden, Peeters Eliana, Van Keer Severien, Vorsters Alex, et al. , Archives of Public Health, Jan-12-2021, Volume 79, Issue 1, (2021)
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework, Dhillon, Sharon, Oštrbenk Valenčak, Anja, Xu Lan, Poljak Mario, and Arbyn M. , Journal of Clinical Microbiology, May-03-2022, (2021)
The European response to the WHO call cervical cancer as a public health problem, Arbyn, M., Gultekin Murat, Morice Philippe, Nieminen Pekka, Cruickshank Maggie, Poortmans Philip, Kelly Daniel, Poljak Mario, Bergeron Christine, Ritchie David, et al. , International Journal of Cancer, Mar-01-2022, Volume 148, Issue 2, (2021)
Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load, Mestdagh, Pieter, Gillard Michel, Dhillon Sharon, Pirnay Jean-Paul, Poels J, Hellemans Jan, Hutse Veronik, Vermeiren Celine, Boutier Maxime, De Wever Veerle, et al. , The Journal of Molecular Diagnostics, Jan-10-2021, Volume 23, Issue 10, (2021)
Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load., Mestdagh, Pieter, Gillard Michel, Dhillon Sharon, Pirnay Jean-Paul, Poels J, Hellemans Jan, Hutse Veronik, Vermeiren Celine, Boutier Maxime, De Wever Veerle, et al. , J Mol Diagn, 2021 Oct, Volume 23, Issue 10, (2021)
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study, Simoens, Cindy, Gorbaslieva Ivana, Gheit Tarik, Holzinger Dana, Lucas Eric, Ridder Ruediger, Rehm Susanne, Vermeulen Peter, Lammens Martin, Vanderveken Olivier, et al. , Cancer Epidemioly, jun 2021, Volume 72, (2021)

QR code

QR code for this page URL